Subchronic and chronic PCP treatment produces temporally distinct deficits in attentional set shifting and prepulse inhibition in rats

Egerton, Alice and Reid, Lee and McGregor, Sandie and Cochran, Susan M. and Morris, Brian J. and Pratt, Judith (2008) Subchronic and chronic PCP treatment produces temporally distinct deficits in attentional set shifting and prepulse inhibition in rats. Psychopharmacology, 198 (1). pp. 37-49. ISSN 0033-3158

Full text not available in this repository.Request a copy from the Strathclyde author

Abstract

We have previously demonstrated that subchronic (five daily administrations of 2.6 mg/kg PCP) and chronic intermittent administration of 2.6 mg/kg PCP to rats produces hypofrontality and other neurochemical changes akin to schizophrenia pathology (Cochran et al., Neuropsychopharmacology, 28:265-275, 2003). We sought to determine whether behavioral alterations related to discrete aspects of schizophrenia are also induced by these PCP treatment regimes. Following administration of vehicle or PCP according to the protocols described above, rats were assessed for attentional set shifting ability, prepulse inhibition (PPI), or social interaction and the locomotor response to a challenge dose of amphetamine. Ability to shift attentional set was impaired 72 h after the last PCP administration following the subchronic and chronic intermittent treatment regimes. PPI was disrupted after each acute administration of PCP in animals under the subchronic treatment regime. However, PPI deficits were not sustained 72 h after the last of five daily administrations. In subchronic and chronic PCP treated animals, no change was found in social interaction behavior, and there was little change in baseline or amphetamine-stimulated locomotor activity, employed as an indicator of dopaminergic hyperfunction. The temporally distinct behavioral effects of these PCP treatment regimes suggest that PPI deficits relate directly to acute NMDA receptor antagonism, whereas the more enduring set shifting deficits relate to the longer term consequences of NMDA receptor blockade. Therefore, these subchronic and chronic PCP treatment regimes produce hypofrontality (Cochran et al., Neuropsychopharmacology, 28:265-275, 2003) and associated prefrontal cortex-dependent deficits in behavioral flexibility which mirror core deficits in schizophrenia.

Creators(s): Egerton, Alice, Reid, Lee, McGregor, Sandie, Cochran, Susan M., Morris, Brian J. and Pratt, Judith;
Item type:Article
ID code:13056
Keywords:phencyclidine, attentional set-shifting, prepulse inhibition, schizophrenia, prefrontal cortex, social interaction, Therapeutics. Pharmacology, Pharmacy and materia medica, Microbiology, Pharmacology
Subjects:Medicine > Therapeutics. Pharmacology
Medicine > Pharmacy and materia medica
Science > Microbiology
Department:Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences
Depositing user: Ms Ann Barker-Myles
Date deposited:16 Sep 2009 11:27
Last modified:31 Jul 2020 01:05
URI:https://strathprints.strath.ac.uk/id/eprint/13056
Export data:
CORE (COnnecting REpositories)